Advertisement

Case-Control Studies in Aging Research

  • Sergio Sánchez-GarcíaEmail author
  • Erika Heredia-Ponce
  • Luis Pablo Cruz-Hervert
  • Ángel Cárdenas-Bahena
  • Laura Bárbara Velázquez-Olmedo
  • Carmen García-Peña
Chapter

Abstract

In the planning phase of research related to age and aging, the quality of knowledge derived from epidemiological studies, depends heavily on the solidity of the methodological design and the strategies for collecting data designed to answer the research question. The classic design of case-control studies distinguishes between older adults who have a specific outcome or disease (cases) and those who do not (controls) and are determines whether the subjects were exposed or not to one or several factors to try to establish, retrospectively (that is, from the effect to the cause), the relationship of these factors with the disease. Case-control studies are a cost-effective alternative for providing a valid and reasonably precise estimate for identifying an association force of a hypothetical relationship cause-effect in studies related to older adults. Recently case-control studies have been related directly to cohort studies, which enabled researchers to design new patterns for their development while obtaining major benefits. The case-control study is the appropriate choice and at times the only alternative for studying diseases of very low incidence in older adults. With this type of study, it is possible to explore a broad range of related exposures to illness. Another important advantage is that they require smaller samples and are less costly than experimental designs or cohort studies. Among the disadvantages or drawbacks of this type of study is that it can only provide information about the event or target disease in the population that has been selected for carrying out the study.

Keywords

Case-control studies Cause-effect Low-incidence studies 

References

  1. 1.
    Bolúmar-Montrúll F (2011) Estudios de casos y controles. In: Hernández-Aguado I, Gil de Miguel A, Delgado-Rodríguez M (eds) Manual de epidemiología y salud pública : para grados en ciencias de la salud, 2nd edn. Médica Panamericana, Madrid, pp 135–145Google Scholar
  2. 2.
    Rothman KJ, Greenland S, Lash TL (2008) Modern epidemiology, 3rd edn. Wolters Kluwer Health/Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  3. 3.
    McGwin G Jr, Sims RV, Pulley L, Roseman JM (2000) Relations among chronic medical conditions, medications, and automobile crashes in the elderly: a population-based case-control study. Am J Epidemiol 152:424–431.  https://doi.org/10.1093/aje/152.5.424 CrossRefPubMedGoogle Scholar
  4. 4.
    Mahillo-Fernandez I, de Pedro-Cuesta J, Bleda MJ, Cruz M, Mølbak K, Laursen H et al (2008) Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies. Neuroepidemiology 31:229–240.  https://doi.org/10.1159/000163097 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM et al (2011) Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control 22:1121–1131.  https://doi.org/10.1007/s10552-011-9787-7 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Coutinho ES, Fletcher A, Bloch KV, Rodrigues LC (2008) Risk factors for falls with severe fracture in elderly people living in a middle-income country: a case control study. BMC Geriatr 8:21.  https://doi.org/10.1186/1471-2318-8-21 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Christensen S, Mehnert F, Chapurlat RD, Baron JA, Sorensen HT (2011) Oral bisphosphonates and risk of ischemic stroke: a case-control study. Osteoporos Int 22:1773–1779.  https://doi.org/10.1007/s00198-010-1395-y CrossRefPubMedGoogle Scholar
  8. 8.
    Lazcano-Ponce E, Salazar-Martinez E, Hernandez-Avila M (2001) Case-control epidemiological studies: theoretical bases, variants and applications. Salud Publica Mex 43:135–150CrossRefGoogle Scholar
  9. 9.
    González A, García-Rodríguez LA (2003) Estudios de cohortes y de casos y controles: qué podemos esperar de ellos. Gastroenterol Hepatol Contin 2:44–48Google Scholar
  10. 10.
    Gordis L (2014) Chapter 10 case-control and other study designs. In: Gordis L (ed) Epidemiology, 5th edn. Elsevier/Saunders, Philadelphia, pp 189–214Google Scholar
  11. 11.
    Tambyraja AL, Sengupta F, MacGregor AB, Bartolo DC, Fearon KC (2004) Patterns and clinical outcomes associated with routine intravenous sodium and fluid administration after colorectal resection. World J Surg 28:1046–1051; discussion 51–2.doi: https://doi.org/10.1007/s00268-004-7383-7 CrossRefGoogle Scholar
  12. 12.
    Bosco JL, Antonsen S, Sørensen HT, Pedersen L, Lash TL (2011) Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark. Cancer Epidemiol Biomark Prev 20:101–111.  https://doi.org/10.1158/1055-9965 CrossRefGoogle Scholar
  13. 13.
    Mittleman MA, Maclure M, Sherwood JB, Mulry RP, Tofler GH, Jacobs SC et al (1995) Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators. Circulation 92:1720–1725CrossRefGoogle Scholar
  14. 14.
    Freedman DM, Dosemeci M, Alavanja MC (2000) Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med 57:418–421.  https://doi.org/10.1136/oem.57.6.418 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Wingo PA, Higgins JE, Rubin GL, Zahniser SC (eds) (1994) An epidemiologic approach to reproductive health. WHO, GenevaGoogle Scholar
  16. 16.
    Elashoff JD, Lemeshow S (2005) Sample size determination in epidemiologic studies. In: Ahrens W, Pigeot I (eds) Handbook of epidemiology. Springer, Heidelberg, pp 559–594Google Scholar
  17. 17.
    Gómez-Gómez M, Danglot-Banck C, Huerta-Alvarado SG, García-de-la-Torre G (2003) El estudio de casos y controles: su diseño, análisis e interpretación, en investigación clínica. Rev Mex Ped 70:257–263Google Scholar
  18. 18.
    Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763CrossRefGoogle Scholar
  19. 19.
    Sánchez-García S, Juárez-Cedillo T, Gallegos-Carrillo K, Gallo JJ, Wagner FA, García-Peña C (2012) Frecuencia de los síntomas depresivos entre adultos mayores de la ciudad de México. Salud Ment 35:71–77Google Scholar
  20. 20.
    Lee LK, Shahar S, Rajab N, Yusoff NA, Jamal RA, Then SM (2013) The role of long chain omega-3 polyunsaturated fatty acids in reducing lipid peroxidation among elderly patients with mild cognitive impairment: a case-control study. J Nutr Biochem 24:803–808.  https://doi.org/10.1016/j.jnutbio.2012.04.014 CrossRefPubMedGoogle Scholar
  21. 21.
    Suzuki T, Yoshida H, Hashimoto T, Yoshimura N, Fujiwara S, Fukunaga M et al (1997) Case-control study of risk factors for hip fractures in the Japanese elderly by a Mediterranean osteoporosis study (MEDOS) questionnaire. Bone 21:461–467CrossRefGoogle Scholar
  22. 22.
    Dadonienė J, Žagminas K, Beržanskytė A (2013) Introduction to research methodology. Vilniaus universitetas: Vilniaus universiteto leidykla, VilniusGoogle Scholar
  23. 23.
    Delgado-Rodríguez M, Llorca J (2004) Bias J Epidemiol Community Health 58(8):635–641Google Scholar
  24. 24.
    Feinstein AR (1979) Methodologic problems and standards in case-control research. In: Ibrahim MA (ed) The case-control study consensus and controversy, Pergamon, pp 35–41Google Scholar
  25. 25.
    Bosch X, Formiga F, López-Soto A (2012) Lupus eritematoso sistémico en el anciano. Rev Esp Geriatr Gerontol 47:71–75.  https://doi.org/10.1016/j.regg.2011.11.005 CrossRefPubMedGoogle Scholar
  26. 26.
    Yokoyama T, Usui T, Kiyama K, Nakashima R, Yukawa N, Kawabata D et al (2010) Two cases of late-onset drug-induced lupus erythematosus caused by ticlopidine in elderly men. Mod Rheumatol 20:405–409.  https://doi.org/10.1007/s10165-010-0289-3 CrossRefPubMedGoogle Scholar
  27. 27.
    Bianchi GD, Cerhan JR, Parker AS, Putnam SD, See WA, Lynch CF et al (2000) Tea consumption and risk of bladder and kidney cancers in a population-based case-control study. Am J Epidemiol 151:377–383CrossRefGoogle Scholar
  28. 28.
    Vila-Corcoles A, Salsench E, Rodriguez-Blanco T, Ochoa-Gondar O, de Diego C, Valdivieso A et al (2009) Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study. Vaccine 27:1504–1510.  https://doi.org/10.1016/j.vaccine.2009.01.013 CrossRefPubMedGoogle Scholar
  29. 29.
    Hernandez-Avila M, Garrido F, Salazar-Martinez E (2000) Biases in epidemiological studies. Salud Publica Mex 42:438–446PubMedGoogle Scholar
  30. 30.
    Budson AE, Price BH (2005) Memory dysfunction. N Engl J Med 352:692–699.  https://doi.org/10.1056/NEJMra041071 CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Sergio Sánchez-García
    • 1
    Email author
  • Erika Heredia-Ponce
    • 2
  • Luis Pablo Cruz-Hervert
    • 3
  • Ángel Cárdenas-Bahena
    • 1
  • Laura Bárbara Velázquez-Olmedo
    • 4
  • Carmen García-Peña
    • 5
  1. 1.Research Unit in Epidemiology and Health Services, Aging Area, National Medical Center Century XXIMexican Institute of Social SecurityMexico CityMexico
  2. 2.Department of Public Health and Oral Epidemiology, Faculty of DentistryNational Autonomous University of MexicoMexico CityMexico
  3. 3.Center for Research on Infectious DiseasesNational Institute of Public HealthMexico CityMexico
  4. 4.Faculty of DentistryNational Autonomous University of MexicoMexico CityMexico
  5. 5.Research DivisionNational Institute of GeriatricsMexico CityMexico

Personalised recommendations